Lazarena, Ludelyn .

HRN: 24-51-27  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/27/2024
CEFUROXIME 500MG (TAB)
01/27/2024
02/03/2024
PO
500 Mg Tab
BID
Thickly MSAF
Waiting Final Action 

Indication:  Prophylaxis    Type of Infection:  Prophylaxis    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: